ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
5 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
|
|
kpt3891
|
55 |
18K |
11 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
55
|
18K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
kpt3891
|
56 |
15K |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
56
|
15K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
11 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
11
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
|
|
kpt3891
|
55 |
18K |
13 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
55
|
18K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
8 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed CEO Announces Departure
|
|
kpt3891
|
37 |
14K |
4 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
37
|
14K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed CEO Announces Departure
|
|
kpt3891
|
37 |
14K |
18 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
37
|
14K
|
18
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
4 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Bad News for PAXLOVID
|
|
kpt3891
|
83 |
27K |
17 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
83
|
27K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Bad News for PAXLOVID
|
|
kpt3891
|
83 |
27K |
5 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
83
|
27K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
7 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
13 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
13
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
5 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
3 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
472
|
183K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
4 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
472
|
183K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
3 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
472
|
183K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
4 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
472
|
183K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
3 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
472
|
183K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
472
|
183K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
3 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
472
|
183K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M US Patent Grant and Program Update
|
|
kpt3891
|
21 |
10K |
17 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
21
|
10K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
14 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
472
|
183K
|
14
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
1 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
472
|
183K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
kpt3891
|
3.2K |
1.0M |
11 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
472
|
183K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
17 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
472
|
183K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
4 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
472
|
183K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
6 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
472
|
183K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
472
|
183K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
472
|
183K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
4 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
472
|
183K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
10 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
472
|
183K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
7 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
153
|
57K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
9 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
472
|
183K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
16 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
472
|
183K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
8 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
472
|
183K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
|
|
kpt3891
|
472 |
183K |
9 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
472
|
183K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
8 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
153
|
57K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
6 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
153
|
57K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
10 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
153
|
57K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
CEOE's Slow and Steady Approach to Potential Partners and Funding
|
|
kpt3891
|
2 |
1.4K |
13 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
2
|
1.4K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
6 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
153
|
57K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Funding Structure
|
|
kpt3891
|
153 |
57K |
11 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
153
|
57K
|
11
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
kpt3891
|
95 |
40K |
4 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
95
|
40K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
kpt3891
|
3.2K |
1.0M |
14 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
14
|
|
ASX - By Stock
|
BIT |
Re:
HIV RESULTS DUE SOON
|
|
kpt3891
|
35 |
15K |
18 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
35
|
15K
|
18
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
kpt3891
|
3.2K |
1.0M |
11 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
11
|
|